CD4+ T cells are the major predictor of HCMV control in allogeneic stem cell transplant recipients on letermovir prophylaxis

INTRODUCTION: Human cytomegalovirus (HCMV) causes significant morbidity and mortality in allogeneic stem cell transplant (alloSCT) recipients. Recently, antiviral letermovir prophylaxis during the first 100 days after alloSCT replaced PCR-guided preemptive therapy as the primary standard of care for...

Descripción completa

Detalles Bibliográficos
Autores principales: Lauruschkat, Chris David, Muchsin, Ihsan, Rein, Alice, Erhard, Florian, Grathwohl, Denise, Dölken, Lars, Köchel, Carolin, Falk, Christine Susanne, Einsele, Hermann, Wurster, Sebastian, Grigoleit, Götz Ulrich, Kraus, Sabrina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206124/
https://www.ncbi.nlm.nih.gov/pubmed/37234158
http://dx.doi.org/10.3389/fimmu.2023.1148841

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206124/
https://www.ncbi.nlm.nih.gov/pubmed/37234158
http://dx.doi.org/10.3389/fimmu.2023.1148841

Ejemplares similares